Active Ingredient: MIRABEGRON
Proprietary Name: MIRABEGRON
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 25MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A209488
Product Number: 001
Approval Date: Sep 29, 2022
Applicant Holder Full Name: ZYDUS PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information